David D Chang - Net Worth and Insider Trading
David D Chang Net Worth
The estimated net worth of David D Chang is at least $23 Million dollars as of 2025-04-26. David D Chang is the President and CEO of Allogene Therapeutics Inc and owns about 8,189,765 shares of Allogene Therapeutics Inc (ALLO) stock worth over $13 Million. David D Chang is also the EVP, R&D, Chief Medical Off. of Kite Pharma Inc and owns about 57,423 shares of Kite Pharma Inc (KITE) stock worth over $10 Million. Details can be seen in David D Chang's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David D Chang has not made any transactions after 2025-03-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David D Chang
David D Chang Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David D Chang owns 2 companies in total, including Allogene Therapeutics Inc (ALLO) , and Kite Pharma Inc (KITE) .
Click here to see the complete history of David D Chang’s form 4 insider trades.
Insider Ownership Summary of David D Chang
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ALLO | Allogene Therapeutics Inc | 2025-03-14 | director & President and CEO |
| KITE | Kite Pharma Inc | 2017-10-03 | EVP & R&D & Chief Medical Off. |
David D Chang Latest Holdings Summary
David D Chang currently owns a total of 2 stocks. Among these stocks, David D Chang owns 8,189,765 shares of Allogene Therapeutics Inc (ALLO) as of March 14, 2025, with a value of $13 Million and a weighting of 55.15%. David D Chang also owns 57,423 shares of Kite Pharma Inc (KITE) as of September 25, 2017, with a value of $10 Million and a weighting of 44.85%.
Latest Holdings of David D Chang
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics Inc | 2025-03-14 | 8,189,765 | 1.55 | 12,694,136 |
| KITE | Kite Pharma Inc | 2017-09-25 | 57,423 | 179.79 | 10,324,081 |
Holding Weightings of David D Chang
David D Chang Form 4 Trading Tracker
According to the SEC Form 4 filings, David D Chang has made a total of 4 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Allogene Therapeutics Inc is the sale of 46,668 shares on March 14, 2025, which brought David D Chang around $91,469.
According to the SEC Form 4 filings, David D Chang has made a total of 0 transactions in Kite Pharma Inc (KITE) over the past 5 years. The most-recent trade in Kite Pharma Inc is the sale of 7,927 shares on September 25, 2017, which brought David D Chang around $1 Million.
Insider Trading History of David D Chang
- 1
David D Chang Trading Performance
GuruFocus tracks the stock performance after each of David D Chang's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David D Chang is 3.67%. GuruFocus also compares David D Chang's trading performance to market benchmark return within the same time period. The performance of stocks bought by David D Chang within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David D Chang's insider trading performs compared to the benchmark.
Performance of David D Chang
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.11 | | | | | |
| Relative Return to S&P 500(%) | 0.64 | | | | | |
David D Chang Ownership Network
Ownership Network List of David D Chang
Ownership Network Relation of David D Chang
David D Chang Owned Company Details
What does Allogene Therapeutics Inc do?
Who are the key executives at Allogene Therapeutics Inc?
David D Chang is the director & President and CEO of Allogene Therapeutics Inc. Other key executives at Allogene Therapeutics Inc include GENERAL COUNSEL Earl Martin Douglas , EVP of R&D Zachary Roberts , and CHIEF FINANCIAL OFFICER Geoffrey M. Parker .
Allogene Therapeutics Inc (ALLO) Insider Trades Summary
Over the past 18 months, David D Chang made 2 insider transaction in Allogene Therapeutics Inc (ALLO) with a net sale of 92,671. Other recent insider transactions involving Allogene Therapeutics Inc (ALLO) include a net sale of 59,730 shares made by Deborah M. Messemer , a net sale of 46,031 shares made by Zachary Roberts , and a net sale of 20,421 shares made by Franz B Humer .
In summary, during the past 3 months, insiders sold 165,416 shares of Allogene Therapeutics Inc (ALLO) in total and bought 0 shares, with a net sale of 165,416 shares. During the past 18 months, 259,453 shares of Allogene Therapeutics Inc (ALLO) were sold and 1,724,327 shares were bought by its insiders, resulting in a net purchase of 1,464,874 shares.
Allogene Therapeutics Inc (ALLO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Allogene Therapeutics Inc Insider Transactions
David D Chang Mailing Address
Above is the net worth, insider trading, and ownership report for David D Chang. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, David D Chang's mailing address is: South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
